{{Rsnum
|rsid=3820129
|Gene=BCL9
|Chromosome=1
|position=147620166
|Orientation=minus
|ReferenceAllele=C
|MissenseAllele=T
|GMAF=0.2176
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BCL9
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.8 | 49.1 | 32.1
| HCB | 0.0 | 16.9 | 83.1
| JPT | 0.0 | 15.0 | 85.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 10.5 | 89.5
| CHB | 0.0 | 16.9 | 83.1
| CHD | 0.9 | 13.1 | 86.0
| GIH | 5.0 | 39.0 | 56.0
| LWK | 0.0 | 8.2 | 91.8
| MEX | 3.6 | 32.1 | 64.3
| MKK | 0.6 | 15.4 | 84.0
| TSI | 14.7 | 52.0 | 33.3
| HapMapRevision=28
}}{{Venter SNP
|rsid=3820129
|allele=T
|frequency=0.442
|uid=1103675218327
|type=heterozygous_SNP
|hugo=BCL9
|ensembl gene=ENSG00000116128
|ensembl transcript=ENST00000234739
|sift=TOLERATED
|disease=A chromosomal aberration involving BCL9 is found in a patient with precusor B-cell acute lymphoblastic leukemia (ALL). Translocation t(1;14)(q21;q32). This translocation leaves the coding region intact, but may have pathogenic effects due to alterations in the expression level of BCL9. Several cases of translocations within the 3' untranslated region of BCL9 have been found in B-cell malignancies.
}}

{{GET Evidence
|gene=BCL9
|aa_change=Pro671Ser
|aa_change_short=P671S
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3820129
|overall_frequency_n=3181
|overall_frequency_d=10758
|overall_frequency=0.295687
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=20
|n_articles=0
|n_articles_annotated=0
|nblosum100=3
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}